UK markets closed

Pharma Mar, S.A. (0RC6.IL)

IOB - IOB Delayed price. Currency in EUR
Add to watchlist
31.72+0.96 (+3.12%)
At close: 12:56PM BST
Currency in EUR

Valuation measures4

Market cap (intra-day) 545.19M
Enterprise value 425.74M
Trailing P/E 278.05
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.39
Price/book (mrq)2.85
Enterprise value/revenue 2.63
Enterprise value/EBITDA 141.82

Trading information

Stock price history

Beta (5Y monthly) -0.04
52-week change 3-15.85%
S&P500 52-week change 322.38%
52-week high 343.74
52-week low 326.12
50-day moving average 329.11
200-day moving average 334.45

Share statistics

Avg vol (3-month) 31.98k
Avg vol (10-day) 31.03k
Shares outstanding 517.79M
Implied shares outstanding 618.07M
Float 814.05M
% held by insiders 127.19%
% held by institutions 112.69%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.65
Forward annual dividend yield 42.09%
Trailing annual dividend rate 30.65
Trailing annual dividend yield 32.11%
5-year average dividend yield 4N/A
Payout ratio 4112.30%
Dividend date 3N/A
Ex-dividend date 407 Jun 2023
Last split factor 21:12
Last split date 322 Jul 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin 11.92%
Operating margin (ttm)8.40%

Management effectiveness

Return on assets (ttm)2.45%
Return on equity (ttm)10.00%

Income statement

Revenue (ttm)175.1M
Revenue per share (ttm)9.74
Quarterly revenue growth (yoy)-4.20%
Gross profit (ttm)182.7M
EBITDA 17.19M
Net income avi to common (ttm)20.87M
Diluted EPS (ttm)1.11
Quarterly earnings growth (yoy)-61.20%

Balance sheet

Total cash (mrq)184.9M
Total cash per share (mrq)10.28
Total debt (mrq)43.68M
Total debt/equity (mrq)20.77%
Current ratio (mrq)3.13
Book value per share (mrq)11.70

Cash flow statement

Operating cash flow (ttm)-702k
Levered free cash flow (ttm)-18.82M